Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine

Go back to Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.00 -0.13 (1.42%)
Previous Close $9.13    52 Week High $9.23 
Open $9.16    52 Week Low $1.16 
Day High $9.37    P/E N/A 
Day Low $8.97    EPS $-0.30 
Volume 3,692,821